Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/61312
Title: Circulating tumor DNA – Current state of play and future perspectives
Contributor(s): De Rubis, Gabriele (author); Krishnan, Sabna Rajeev (author); Bebawy, Mary  (author)orcid 
Publication Date: 2018-10
Early Online Version: 2018-08-22
DOI: 10.1016/j.phrs.2018.08.017
Handle Link: https://hdl.handle.net/1959.11/61312
Abstract: 

Cancer management paradigms are shifting towards a personalized approach thanks to the advent of the -omics technologies. Liquid biopsies, consisting in the sampling of blood and other bodily fluids, are emerging as a valid alternative to circulating tumor biomarkers and tumor tissue biopsies for cancer diagnosis, routine monitoring and prognostication. The content of a liquid biopsy is referred to as the “tumor circulome”. Among its components, circulating tumor DNA (ctDNA), including both cell-free and exosome-associated DNA, is the most widely characterized element. ctDNA analysis has a tremendous capability in the diagnostic arena. Its potential has been demonstrated at each level of disease staging and management and supported by a recent FDA approval for companion diagnostic, and the investments being made by pharmaceutical companies in this sector are numerous. The approaches available for ctDNA analysis allow both quantitative and qualitative studies and range from PCR and dPCR-mediated single/multiple gene mutational assessment to whole genome next generation sequencing and methylation mapping. Although the principal object of a liquid biopsy is blood, other body fluids such as urine and saliva show potential as complementary DNA sources for tumor analysis. In this review we provide a synopsis on the state of play of current ctDNA application. We discuss the clinical significance of ctDNA analysis and review the state of the art of technologies being currently developed to this aim. We also discuss the current issues limiting ctDNA application and highlight the promising approaches being developed to overcome these.

Publication Type: Journal Article
Source of Publication: Pharmacological Research, v.136, p. 35-44
Publisher: Academic Press
Place of Publication: United Kingdom
ISSN: 1096-1186
1043-6618
Fields of Research (FoR) 2020: 3208 Medical physiology
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Appears in Collections:Journal Article
School of Psychology

Show full item record

SCOPUSTM   
Citations

28
checked on Jul 13, 2024
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.